-
1Academic Journal
Συγγραφείς: I. N. Rozhkova, S. V. Okotrub, E. Yu. Brusentsev, T. A. Rakhmanova, D. A. Lebedeva, V. S. Kozeneva, N. A. Shavshaeva, N. V. Khotskin, S. Ya. Amstislavsky, И. Н. Рожкова, С. В. Окотруб, Е. Ю. Брусенцев, Т. А. Рахманова, Д. А. Лебедева, В. С. Козенева, Н. А. Шавшаева, Н. В. Хоцкин, С. Я. Амстиславский
Συνεισφορές: The work was carried out with the support of RNF No. 23-25-00123.
Πηγή: Vavilov Journal of Genetics and Breeding; Том 28, № 7 (2024); 744-751 ; Вавиловский журнал генетики и селекции; Том 28, № 7 (2024); 744-751 ; 2500-3259 ; 10.18699/vjgb-24-75
Θεματικοί όροι: альфа-синуклеин, Parkinson’s disease, motor coordination, dopaminergic brain system, alpha-synuclein, болезнь Паркинсона, координация движений, дофаминергическая система мозга
Περιγραφή αρχείου: application/pdf
Relation: https://vavilov.elpub.ru/jour/article/view/4347/1881; Bae Y.J., Kim J.M., Sohn C.H., Choi J.H., Choi B.S., Song Y.S., Nam Y., Cho S.J., Jeon B., Kim J.H. Imaging the substantia nigra in Parkinson disease and other Parkinsonian syndromes. Radiology. 2021;300:260-278. DOI 10.1148/radiol.2021203341; Beitz J.M. Parkinson’s disease: a review. Front. Biosci. (Schol. Ed.). 2014;6:65-74. DOI 10.2741/S415; Bidesi N.S., Vang Andersen I., Windhorst A.D., Shalgunov V., Herth M.M. The role of neuroimaging in Parkinson’s disease. J. Neurochem. 2021;159:660-689. DOI 10.1111/jnc.15516; Burre J., Sharma M., Sudhof T.C. Cell biology and pathophysiology of α-synuclein. Cold. Spring. Harb. Perspect. Med. 2018;8:a024091. DOI 10.1101/cshperspect.a024091; Case L.K., Del Rio R., Bonney E.A., Zachary J.F., Blankenhorn E.P., Tung K.S., Teuscher C. The postnatal maternal environment affects autoimmune disease susceptibility in A/J mice. Cell Immunol. 2010; 260:119-127. DOI 10.1016/j.cellimm.2009.10.002; Chen D., Liu Y., Shu G., Chen C., Sullivan D.A., Kam W.R., Hann S., Fowler M., Warman M.L. Ocular manifestations of chordin-like 1 knockout mice. Cornea. 2020;39:1145-1150. DOI 10.1097/ICO.0000000000002371; Chia S.J., Tan E.K., Chao Y.X. Historical perspective: models of Parkinson’s disease. Int. J. Mol. Sci. 2020;21:2464. DOI 10.3390/ijms21072464; Crabtree D.M., Zhang J. Genetically engineered mouse models of Parkinson’s disease. Brain Res. Bull. 2012;88:13-32. DOI 10.1016/j.brainresbull.2011.07.019; Deutch A.Y. Striatal plasticity in parkinsonism: dystrophic changes in medium spiny neurons and progression in Parkinson’s disease. J. Neural Transm. Suppl. 2006;70:67. DOI 10.1007/978-3-211-45295-0_12; Dickson D.W. Neuropathology of Parkinson disease. Parkinsonism Relat. Disord. 2018;46:S30-S33. DOI 10.1016/j.parkreldis.2017. 07.033; Dickson D.W., Braak H., Duda J.E., Duyckaerts C., Gasser T., Halliday G.M., Hardy J., Leverenz J.B., Del Tredici K., Wszolek Z.K., Litvan I. Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria. Lancet Neurol. 2009;8:1150-1157. DOI 10.1016/S1474-4422(09)70238-8; Graham D.R., Sidhu A. Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxietylike behavior. J. Neurosci. Res. 2010;88:1777-1183. DOI 10.1002/jnr.22331; Grigoryan G.A., Bazyan A.S. The experimental models of Parkinson’s disease in animals. Uspekhi Fiziologicheskikh Nauk = Progress in Physiological Science. 2007;38:80-88 (in Russian); Halliday G.M., Del Tredici K., Braak H. Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson’s disease. J. Neural Transm. Suppl. 2006;70:99. DOI 10.1007/978-3-211-45295-0_16; Hayes M.T. Parkinson’s disease and parkinsonism. Am. J. Med. 2019; 132:802-807. DOI 10.1016/j.amjmed.2019.03.001; Holmdahl R., Malissen B. The need for littermate controls. Eur. J. Immunol. 2012;42:45-47. DOI 10.1002/eji.201142048; Jellinger K.A. Pathology of Parkinson’s disease. Mol. Chem. Neuropath. 1991;14:153-197. DOI 10.1007/bf03159935; Kalia L.V., Kalia S.K., McLean P.J., Lozano A.M., Lang A.E. α-Synuclein oligomers and clinical implications for Parkinson disease. Ann. Neurol. 2013;73:155-169. DOI 10.1002/ana.23746; Kato M., Kimura M. Effects of reversible blockade of basal ganglia on a voluntary arm movement. J. Neurophysiol. 1992;68:1516-1534. DOI 10.1152/jn.1992.68.5.1516; Korchounov A., Meyer M.F., Krasnianski M. Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation. J. Neural Transm. (Vienna). 2010;117:1359-1369. DOI 10.1007/s00702-010-0454-z; Korolenko T.A., Shintyapina A.B., Belichenko V.M., Pupyshev A.B., Akopyan A.A., Fedoseeva L.A., Russkikh G.S., Vavilin V.A., Tenditnik M.V., Lin C-L., Amstislavskaya T.G., Tikhonova M.A. Early Parkinson’s disease-like pathology in a transgenic mouse model involves a decreased Cst3 mRNA expression but not neuroinflammatory response in the brain. Med. Univer. 2020;3:66-78. DOI 10.2478/medu-2020-0008; Lai T.T., Kim Y.J., Nguyen P.T., Koh Y.H., Nguyen T.T., Ma H.I., Kim Y.E. Temporal evolution of inflammation and neurodegeneration with alpha-synuclein propagation in Parkinson’s disease mouse model. Fron. Int. Neurosci. 2021;15:715190. DOI 10.3389/fnint.2021.715190; Langley M.R., Ghaisas S., Palanisamy B.N., Ay M., Jin H., Anantharam V., Kanthasamy A., Kanthasamy A.G. Characterization of nonmotor behavioral impairments and their neurochemical mechanisms in the MitoPark mouse model of progressive neurodegeneration in Parkinson’s disease. Exp. Neurol. 2021;341:113716. DOI 10.1016/j.expneurol.2021.113716; Lee F.J., Liu F., Pristupa Z.B., Niznik H.B. Direct binding andfunctional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J. 2001;15:916-926. DOI 10.1096/fj.00-0334com; Liu Q., Xu Y., Wan W., Ma Z. An unexpected improvement in spatial learning and memory ability in alpha-synuclein A53T transgenic mice. J. Neural. Transm. (Vienna). 2018;125(2):203-210. DOI 10.1007/s00702-017-1819-3; Maric D., Jahanipour J., Li X.R., Singh A., Mobiny A., Van Nguyen H., Sedlock A., Grama K., Roysam B. Whole-brain tissue mapping toolkit using large-scale highly multiplexed immunofluorescence imaging and deep neural networks. Nat. Commun. 2021;12:1550. DOI 10.1038/s41467-021-21735-x; Nicholas L.M., Ozanne S.E. Early life programming in mice by maternal overnutrition: mechanistic insights and interventional approaches. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2019;374:20180116. DOI 10.1098/rstb.2018.0116; Oaks A.W., Frankfurt M., Finkelstein D.I., Sidhu A. Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function. PLoS One. 2013;8:e60378. DOI 10.1371/journal.pone.0060378; Paumier K.L., Sukoff Rizzo S.J., Berger Z., Chen Y., Gonzales C., Kaftan E., Li L., Lotarski S., Monaghan M., Shen W., Stolyar P., Vasilyev D., Zaleska M., D Hirst W., Dunlop J. Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson’s disease. PLoS One. 2013;8(8):e70274. DOI 10.1371/journal.pone.0070274.; Paxinos G., Franklin K. Mouse Brain in Stereotaxic Coordinates. 4th ed. San Diego: Acad. Press, 2012 Poewe W., Seppi K., Tanner C.M., Halliday G.M., Brundin P., Volkmann J., Schrag A.E., Lang A.E. Parkinson disease. Nat. Rev. Dis. Primers. 2017;3:17013. DOI 10.1038/nrdp.2017.13; Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276:2045-2047. DOI 10.1126/science.276.5321.2045; Pupyshev A.B., Korolenko T.A., Akopyan A.A., Amstislavskaya T.G., Tikhonova M.A. Suppression of autophagy in the brain of transgenic mice with overexpression of А53Т-mutant α-synuclein as an early event at synucleinopathy progression. Neurosci. Lett. 2018;672: 140-144. DOI 10.1016/j.neulet.2017.12.001; Rozhkova I.N., Okotrub S.V., Brusentsev E.Yu., Rakhmanova T.A., Lebedeva D.A., Kozeneva V.S., Khotskin N.V., Amstislavsky S.Ya. Analysis of behavior and brain neuronal density in B6.Cg-Tg(PrnpSNCA*A53T)23Mkle/J mice modeling, a Parkinson’s disease. Rossiyskiy Fiziologicheskiy Zhurnal imeni I.M. Sechenova = Russian Journal of Physiology. 2023;59:1633-1647. DOI 10.31857/S0869813923090091 (in Russian); Schultz W., Ruffieux A., Aebischer P. The activity of pars compacta neurons of the monkey substantia nigra in relation to motor activation. Exp. Brain Res. 1983;51:377-387. DOI 10.1016/0304-3940(84)90456-7; Seo J.H., Kang S.W., Kim K., Wi S., Lee J.W., Cho S.R. Environmental enrichment attenuates oxidative stress and alters detoxifying enzymes in an A53T α-synuclein transgenic mouse model of Parkinson’s disease. Antioxidants (Basel). 2020;9:928. DOI 10.3390/antiox9100928; Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388: 839-840. DOI 10.1038/42166; Stern G. The effects of lesions in the substantia nigra. Brain. 1966;89: 449-478. DOI 10.1093/brain/89.3.449; Taguchi T., Ikuno M., Hondo M., Parajuli L.K., Taguchi K., Ueda J., Sawamura M., Okuda S., Nakanishi E., Hara J., Uemura N., Hatanaka Y., Ayaki T., Matsuzawa S., Tanaka M., El-Agnaf O.M.A., Koike M., Yanagisawa M., Uemura M.T., Yamakado H., Takahashi R. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson’s disease model. Brain. 2020;143:249-265. DOI 10.1093/brain/awz380; Tang H., Gao Y., Zhang Q., Nie K., Zhu R., Gao L., Feng S., Wang L., Zhao J., Huang Z., Zhang Y., Wang L. Chronic cerebral hypoperfusion independently exacerbates cognitive impairment within the pathopoiesis of Parkinson’s disease via microvascular pathologys. Behav. Brain Res. 2017;333:286-294. DOI 10.1016/j.bbr.2017.05.061; Tikhonova M.A., Tikhonova N.G., Tenditnik M.V., Ovsyukova M.V., Akopyan A.A., Dubrovina N.I., Amstislavskaya T.G., Khlestkina E.K. Effects of grape polyphenols on the life span and neuroinflammatory alterations related to neurodegenerative Parkinson disease-like disturbances in mice. Molecules. 2020;25:5339. DOI 10.3390/molecules25225339; Tran J., Anastacio H., Bardy C. Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells. NPJ Parkinsons Dis. 2020;6:8. DOI 10.1038/s41531-020-0110-8; Unger E.L., Eve D.J., Perez X.A., Reichenbach D.K., Xu Y., Lee M.K., Andrews A.M. Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice. Neurobiol. Dis. 2006;21:431- 443. DOI 10.1016/j.nbd.2005.08.005; Van der Putten H., Wiederhold K.H., Probst A., Barbieri S., Mistl C., Danner S., Kauffmann S., Hofele K., Spooren W.P., Ruegg M.A., Lin S., Caroni P., Sommer B., Tolnay M., Bilbe G. Neuropathology in mice expressing human alpha-synuclein. J. Neurosci. 2000;20: 6021-6029. DOI 10.1523/JNEUROSCI.20-16-06021.2000; Venda L., Cragg S., Buchman V.L., Wade-Martins R. α-Synuclein and dopamine at the crossroads of Parkinson’s disease. Trends Neurosci. 2010;12:559-568. DOI 10.1016/j.tins.2010.09.004; Wang Y., Sun Z., Du S., Wei H., Li X., Li X., Shen J., Chen X., Cai Z. The increase of α-synuclein and alterations of dynein in A53T transgenic and aging mouse. J. Clin. Neurosci. 2022;96:154-162. DOI 10.1016/j.jocn.2021.11.002; Wu D., Dean J. Maternal factors regulating preimplantation development in mice. Curr. Top. Dev. Biol. 2020;140:317-340. DOI 10.1016/bs.ctdb.2019.10.006; Zhang Yu., Wu Q., Zhang L., Wang Q., Yang Z., Liu J., Feng L. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson’s disease. Pharmacol. Res. 2019;150:104538. DOI 10.1016/j.phrs.2019.104538; Zhang Yu., Wu Q., Ren Y., Zhang Y., Feng L. A53T α-synuclein induces neurogenesis impairment and cognitive dysfunction in line M83 transgenic mice and reduces the proliferation of embryonic neural stem cells. Brain Res. Bull. 2022;182:118-129. DOI 10.1016/ j.brainresbull.2022.02.010; Zheng M., Liu Y., Xiao Z., Jiao L., Lin X. Tau knockout and α-synuclein A53T synergy modulated parvalbumin-positive neurons degeneration staging in substantia nigra pars reticulata of Parkinson’s disease-liked model. Front. Aging Neurosci. 2022;13:784665. DOI 10.3389/fnagi.2021.784665.; https://vavilov.elpub.ru/jour/article/view/4347
-
2Academic Journal
Συγγραφείς: Геворгян, Маргарита, Кузнецова, Светлана, Альперина, Елизавета
Θεματικοί όροι: ГИППОКАМП, ДОФАМИНЕРГИЧЕСКАЯ СИСТЕМА МОЗГА, ДОФАМИНОВЫЕ D1И D2-РЕЦЕПТОРЫ, ИММУНОМОДУЛЯЦИЯ
Περιγραφή αρχείου: text/html
-
3Academic Journal
Πηγή: Сибирский научный медицинский журнал.
Θεματικοί όροι: ГИППОКАМП, ДОФАМИНЕРГИЧЕСКАЯ СИСТЕМА МОЗГА, ДОФАМИНОВЫЕ D1И D2-РЕЦЕПТОРЫ, ИММУНОМОДУЛЯЦИЯ, 3. Good health
Περιγραφή αρχείου: text/html
-
4Electronic Resource
Additional Titles: Влияние фенамина на поведенческие компоненты обсессивно-компульсивного и аддиктивного игрового поведения в тесте закапывания шариков у крыс
Συγγραφείς: Shabanov P.D., Lebedev A.A., Yakushina N.D., Pshenichnaya A.G., Bychkov E.R.
Πηγή: Reviews on Clinical Pharmacology and Drug Therapy; Vol 14, No 3 (2016); 46-52; Обзоры по клинической фармакологии и лекарственной терапии; Vol 14, No 3 (2016); 46-52; 2542-1875; 1683-4100; 10.17816/RCF143
Όροι ευρετηρίου: obsessive-compulsive behavior; pathological gambling; amphetamine; dopaminergic system of the brain; marble test; rats, обсессивно-компульсивное поведение; игровая зависимость; фенамин; дофаминергическая система мозга; закапывание шариков; крысы, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion
